UCB is a global biopharmaceutical company headquartered in Brussels, Belgium, focusing on innovative treatments for severe diseases in immunology and neurology.

About

Related projects

Projects

Learn more

NEMO

    R&D Advanced Therapies Biopharma

En cours

Learn more

GTRP-DIAT

    R&D Advanced Therapies

En cours

Learn more

Targetum

    R&D Biopharma

Terminé